Oakworth Capital’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Oakworth Capital’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-300	Closed	-$8K	–	573
2022 Q2	$8K	Hold	300	–	–	﹤0.01%	468
2022 Q1	$10K	Hold	300	–	–	﹤0.01%	452
2021 Q4	$13K	Hold	300	–	–	﹤0.01%	460
2021 Q3	$14K	Hold	300	–	–	﹤0.01%	445
2021 Q2	$15K	Hold	300	–	–	﹤0.01%	437
2021 Q1	$15K	Hold	300	–	–	﹤0.01%	426
2020 Q4	$15K	Hold	300	–	–	﹤0.01%	393
2020 Q3	$12K	Buy	+300	New	+$12.4K	﹤0.01%	415

Other funds holding SBIO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

ASB Consultores Aventura, Florida $30.1M AUM 22.96% 1-Year Est. Return

Oakworth Capital's SBIO Position: Q3 2022 in Review

Oakworth Capital sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2022, closing a stake of 300 shares — an estimated $8K sold.

Oakworth Capital first reported a position in SBIO in Q3 2020 and held it in 8 quarters. The position peaked at $15K in Q2 2021. 44 funds tracked by Wall St. Rank hold SBIO as of Q3 2022.

Oakworth Capital reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2022 after selling out during the quarter.
Oakworth Capital sold 300 ALPS Medical Breakthroughs ETF shares in Q3 2022, an estimated $8K.
Oakworth Capital first reported a position in ALPS Medical Breakthroughs ETF in Q3 2020 and held it in 8 quarters.
Oakworth Capital's ALPS Medical Breakthroughs ETF position peaked at $15K in Q2 2021.
44 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2022.

Based on Oakworth Capital's 13F filing for Q3 2022, filed 31 Oct 2022.